Fast insight into nanotechnology

Access easily searchable nanoscience data, synthesis methods and literature

docetaxel-loaded Herceptin modified PLA-TPGS/TPGS-COOH nanoparticles

Based on

1 Articles
2014 Most recent source

Composition

1

PLA-TPGS/TPGS-COOH mixture

Type Complex Compound
Formula
Role carriers
2

1,7β,10β-trihydroxy-9-oxo-5β,20-epoxytax-11-ene-2α,4,13α-triyl 4-acetate 2-benzoate 13-{(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoate}

docetaxel Taxotere Dtxl Doc Dtx
Type Single Compound
Formula C43H53NO14
Role loaded material
3

anti-HER2 antibody

Herceptin
Type Biomolecule
Formula
Role loaded material

Properties

General physical and chemical properties

Property Value Source
drug release

More information available to subscribers only.

Or, view sample content

Applications

Area Application Source
medicine/veterinary

More information available to subscribers only.

Or, view sample content

Characterization

Method Source
dynamic light scattering

More information available to subscribers only.

Or, view sample content

Biological effects

Biological system Test details Source
SK-BR-3 cells

More information available to subscribers only.

Or, view sample content

Preparation

Method 1

Type: Physical formation
Source:
Product

docetaxel-loaded Herceptin modified PLA-TPGS/TPGS-COOH nanoparticles

Method 2

Type: Physical formation
Source:
Product

docetaxel-loaded Herceptin modified PLA-TPGS/TPGS-COOH nanoparticles

Method 3

Type: Chemical synthesis
Source:
Starting materials
  1. tIrMK3VDix0frsVxI99K
  2. 9N7
  3. NUd
  4. HWp
Product

docetaxel-loaded Herceptin modified PLA-TPGS/TPGS-COOH nanoparticles

Method 4

Type: Chemical synthesis
Source:
Starting materials
  1. jH30elPD7p3WasT2l683
  2. VbH
  3. 5rp
  4. VYr
Product

docetaxel-loaded Herceptin modified PLA-TPGS/TPGS-COOH nanoparticles

Method 5

Type: Physical formation
Source:
Product

docetaxel-loaded Herceptin modified PLA-TPGS/TPGS-COOH nanoparticles

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial